Document de presse | 2007.12.18
The Buruli Ulcer is an extremely debilitating skin disease, in full emergence in West Africa. The first results of a case-control study of factors associates with the development underway in the endemic region by the Centre Pasteur du Cameroun, in collaboration with the researchers of many other teams, published in PLoS Neglected Tropical Diseases, confirm the presence of the already suspected...
Document de presse | 2006.01.09
Teams from the Institut Pasteur and the CNRS have just identified a new human genetic factor involved in susceptibility to tuberculosis. Researchers analysed the extent to which variability of the DC-SIGN gene could be involved in susceptibility to become sick after Mycobacterium tuberculosis infections, in a large South African population. They showed that a variant of this gene is over-...
Document de presse | 2004.02.19
Research teams from INSERM and the Institut Pasteur have just discovered the virulence mechanism of the Rift Valley Fever virus. This virus, often fatal in humans, regularly decimates herds of livestock in Africa. Understanding the interactions between the host and this virus should make it possible to identify new therapeutic targets against Rift Valley Fever. This research, published in the...
Article | 2016.12.20
The Faculty of Medicine, University of Szeged aims to give students the possibility to learn about other countries’ higher education and health care systems, and to ensure that the results of its teaching and research activities extend beyond Hungary’s borders. Our international relations encompass the fields of education, research and health care. The Faculty of Medicine, University...
Article | 2017.02.27
Summary The general objective of this course is to give to health professionals, students in healthcare professions and researchers working in the field, the theoretical and practical basics to enable them to design and monitor clinical trials that meet International quality standards as ICH-GCP (International Conference on Harmonization - Good Clinical Practices). This course that addresses...
Document de presse | 2018.11.23
As tumors develop, they evolve genetically. How does the immune system act when faced with tumor cells? How does it exert pressure on the genetic diversity of cancer cells? Scientists from the Institut Pasteur and Inserm used in vivo video techniques and cell-specific staining to visualize the action of immune cells in response to the proliferation of cancer cells. The findings have been...
Portrait | 2018.09.04
You have no doubt already heard about emerging viruses. The international media regularly informs us about viruses raging across the world, for instance Zika, Ebola and dengue. But where do they come from? Mosquitoes, bats, rodents and primates carry viruses, and when humans share an area with these species, they are exposed to various infectious risks. To shed light on this situation, known as...
News | 2019.11.18
Faithful to the Pasteurian mission that aims to tackle human public health issues, the Institut Pasteur is involved in research on ageing. Seeking understand the decline in function of tissues in organisms, researchers from the Stem Cells and Development unit at Institut Pasteur made a discovery on the still unknown mechanisms of the epigenetic clock in stem cells.Epigenetic modifications have...
Document de presse | 2020.03.10
How does the immune system act to limit tumor development? Using in vivo imaging tools, scientists from the Institut Pasteur and Inserm described the spatiotemporal activity of tumor-infiltrating T lymphocytes, both locally and remotely. Their research was published in the journal Nature Cancer on March 9, 2020.Some cells in the immune system, like T lymphocytes, are capable of attacking cancer...
Document de presse | 2021.03.23
SARS-CoV-2, the virus responsible for COVID-19, is capable of infecting some species, while others are naturally resistant to it. This determines the "host range" of the virus. The SARS-CoV-2 host range includes humans, non-human primates, hamsters, mink and cats. Since the start of the pandemic, mice and rats had proven to be resistant to SARS-CoV-2, because their ACE2 receptor, which allows the...